EU approves treatment for prostate cancer
The European Union has approved a new treatment against an advanced type of prostate cancer by Novartis, the Swiss pharmaceutical giant said Tuesday.
Dec 13, 2022
0
4
The European Union has approved a new treatment against an advanced type of prostate cancer by Novartis, the Swiss pharmaceutical giant said Tuesday.
Dec 13, 2022
0
4
Swiss pharmaceuticals company Novartis said Thursday that it plans to spin off its generics subsidiary Sandoz, which generated nearly $10 billion in revenue last year.
Aug 25, 2022
0
17
Two children who received Zolgensma, a gene therapy produced by Swiss drugmaker Novartis to treat spinal muscular atrophy, have died from liver failure, the company said Friday.
Aug 12, 2022
0
13
Swiss pharmaceutical giant Novartis said Wednesday it was to acquire a UK-based biotech company developing gene therapies for eye diseases called Gyroscope Therapeutics.
Dec 22, 2021
0
2
Swiss pharmaceuticals giant Novartis said Thursday it has signed a new agreement to farm out some of its production facilities and help manufacture much-needed doses of the Pfizer-BioNTech coronavirus vaccine.
Oct 21, 2021
0
6
Novartis announced Thursday it will join forces with fellow Swiss pharmaceutical giant Roche to produce tocilizumab, a drug being tested for its effectiveness against COVID-19-linked pneumonia.
Apr 15, 2021
0
3
EU regulators have approved Novartis's new Piqray drug to treat advanced breast cancer, the Swiss pharma giant said Wednesday.
Jul 29, 2020
0
5
Novartis agreed to pay around $336 million to settle US charges connected to bribery schemes aimed at increasing sales of its pharmaceutical products, US authorities announced Thursday.
Jun 25, 2020
0
5
Swiss pharmaceutical giant Novartis said Wednesday it would not hike drug prices in the United States this year, following a similar decision by rival Pfizer amid pressure from the White House.
Jul 18, 2018
0
0
The U.S. Food and Drug Administration (FDA) has expanded approval for a personalized cellular therapy developed at the University of Pennsylvania's Abramson Cancer Center, this time for the treatment of adult patients with ...
May 1, 2018
0
128
Novartis International AG is a multinational pharmaceutical company based in Basel, Switzerland, ranking number one in revenues, which accounted over $53 billion in 2008, and number three in sales, which accounted 36.172 billon in 2008 . Novartis is one of the largest healthcare companies in the world and a leading giant among pharmaceutical companies. Novartis manufactures drugs such as clozapine (Clozaril), diclofenac (Voltaren), carbamazepine (Tegretol), valsartan (Diovan), imatinib mesylate (Gleevec / Glivec), cyclosporin A (Neoral / Sandimmun), letrozole (Femara), methylphenidate (Ritalin), terbinafine (Lamisil), and others. Novartis owns Sandoz, a large manufacturer of generic drugs. The company formerly owned the Gerber Products Company, a major infant and baby products producer, but sold it to Nestlé on 1 September 2007.
Novartis is a full member of the European Federation of Pharmaceutical Industries and Associations (EFPIA).
This text uses material from Wikipedia, licensed under CC BY-SA